A delegation from the China Council for the promotion of drugs held talks with the government of Ontario, Canada (a series of reports on the visit to the United States and Canada 9)

Source: China Council for the promotion of Medicine (CFDA) on July 16, 2013, a delegation led by song Ruilin, executive chairman of CFDA, was invited to hold a business negotiation with representatives of the Ontario government of Canada at the Ontario investment and Trade Center in Toronto The delegation was led by Ren Wuxian, chairman of Yabao Pharmaceutical Group, Jin Quanyuan, director of scientific research department of Shenyang Pharmaceutical University, Li Minghua, deputy general manager of Shanxi Zhendong Pharmaceutical Co., Ltd., Xie Licheng, deputy general manager of Changzhou Fangyuan Pharmaceutical Co., Ltd., Zhao Jing, deputy general manager of R & D center of Meiluo Pharmaceutical Co., Ltd., Ou Lingyun, technical director of Guizhou Xinbang pharmaceutical, and Chen Changxiong, Executive Deputy Secretary General of China Pharmaceutical Council Wang Xin, deputy director of international affairs Yang Shaojun, consul of science and technology and Wu shanlue, Vice Consul of the Chinese Consulate General in Toronto attended the meeting During the talks, sandy he Easton, senior advisor of international trade policy of Ontario Ministry of economy, trade and technology innovation, first extended a warm welcome on behalf of the Ontario government to the visit of the delegation of China Council for the promotion of drugs Later, Leigh Davison, director of life science program, Department of science and technology innovation, Ontario government, and Jessica Wu, a business investment expert, respectively introduced the overall situation and investment environment of medicine and health care in Ontario Song Ruilin, executive chairman, on behalf of the China Pharmaceutical Association, thanked Canada for its invitation and arrangement President Song said that the talks enabled Chinese enterprises to have a deep understanding of the investment environment and technological resources of Ontario Canada is a diversified country We hope that the pharmaceutical industry of China and Canada can carry out exchanges in a diversified way, so that bilateral cooperation will continue to achieve new success In the docking process of innovation projects, representatives from scientific research institutions such as Mars, Ontario Brain Institute, parteq innovations and CAMH respectively introduced their companies to Chinese entrepreneurs and more than 20 pharmaceutical innovation projects These projects mainly focus on anti-tumor, diabetes, mental illness and so on The representatives of China and Canada held in-depth discussions and exchanges on bilateral technology and economic and trade cooperation and research and development of specific innovation projects In the afternoon, the delegation, accompanied by representatives of the Ontario government, visited the Ontario Cancer Research Institute (oicr) Jeff Courtney, CEO of oicr, and Thomas J Hudson, President of oicr received Chinese representatives, who introduced the basic situation of the Research Institute, the research results of anticancer drugs that have been achieved and the forms of cooperation with the outside world The Institute is the largest pharmaceutical research institution invested by the Ontario government (with a financial support of 150 million Canadian dollars per year), with 1600 researchers working here, and has successfully incubated 15 pharmaceutical companies The delegation of the China Council for the promotion of drugs showed strong interest in the research strength and achievements of the Institute and expressed its willingness to carry out specific cooperation in the future After the meeting, the delegation visited the laboratory of the Institute The visit of the delegation of China Council for the promotion of drugs in Toronto was a complete success It had in-depth exchanges with local governments, enterprises and scientific research institutions, obtained cutting-edge information on medical research and pharmaceutical research, and learned about the cooperation mode between scientific research institutions and industry in Canada, which is of great significance to us Meeting site between the delegation of China Council for the promotion of medicine and the government of Ontario Ms sandy he Easton, executive chairman of song Ruilin and senior advisor of international trade policy of the Ministry of economy, trade and technology innovation of Ontario Delegation of China Council for the promotion of medicine and the delegation of Ontario government Delegation of China Council for the promotion of medicine visited Cancer Research Institute of Ontario Song Ruilin, executive chairman, and Thomas J Hudson, President of Ontario Cancer Institute